We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00396838
First Posted: November 8, 2006
Last Update Posted: October 15, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rambam Health Care Campus
  Purpose

Background: Heel lancing is a routine procedure for the diagnosis of phenylketonuria in infants. Despite the short- and long-term adverse effects of pain, there are no guidelines for the reduction of such pain. Previous studies evaluated different treatment modalities; however, in most of them, pain response was assessed by subjective measures.

Aims of study: 1. To characterize the pain response of infants by using a computerized analysis of the ECG. 2. To compare six different methods of pain reduction during heel lancing in newborns.

Methods: The time, geometric and frequency domains of the infants' ECG will be computed during heel lancing. 150 healthy full-term infants will be evaluated in six treatment groups: breastfeeding, bottle feeding, skin-to-skin contact, lying on a table without anything, lying with a pacifier and lying while getting a glucose solution. The differences in pain response to these six treatment modalities will be assessed and compared to the infants' length of cry, and scoring of the infants' behavioral response.


Condition
Pain

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates

Further study details as provided by Rambam Health Care Campus:

Estimated Enrollment: 300
Study Start Date: November 2006
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 72 Hours   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • normal full-term newborns (>38 weeks)
  • Apgar score >=8 at five minutes after delivery.

Exclusion Criteria:

  • congenital anomalies
  • medical complications
  • need for oxygen administration
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00396838


Locations
Israel
Rambam MC
Haifa, Israel
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Study Director: Amir Weissman, MD Rambam MC
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00396838     History of Changes
Other Study ID Numbers: 1909CTIL
First Submitted: November 7, 2006
First Posted: November 8, 2006
Last Update Posted: October 15, 2008
Last Verified: March 2008